Isoniazid preventive therapy in HIV-infected and -uninfected children (0 - 14 years)
dc.contributor.author | Schaaf, H. Simon | en_ZA |
dc.contributor.author | Cotton, Mark F. | en_ZA |
dc.contributor.author | Boon, Gerald P. G. | en_ZA |
dc.contributor.author | Jeena, Prakash M. | en_ZA |
dc.date.accessioned | 2014-07-07T12:33:10Z | |
dc.date.available | 2014-07-07T12:33:10Z | |
dc.date.issued | 2013-09-04 | |
dc.description | CITATION: Schaaf, H. S., Cotton, M. F., Boon, G. P. G. & Jeena, P. M. 2013. Isoniazid preventive therapy in HIV-infected and -uninfected children (0 - 14 years). South African Medical Journal, 103(10):714-715, doi:10.7196/SAMJ.7189. | en_ZA |
dc.description | The original publication is available at http://www.samj.org.za | en_ZA |
dc.description.abstract | Isoniazid preventive therapy (IPT) prevents tuberculosis (TB) in immunocompetent children <5 years of age after exposure to an infectious TB source case. Routine IPT has been advocated in all HIV-infected children without TB, but has been controversial. Antiretroviral therapy markedly reduces the risk for TB in HIV-infected children, especially when started early in infancy. In HIV-infected children, as in HIV- uninfected children, we recommend post-exposure IPT after each TB exposure episode; but in HIV-infected children, this should be given irrespective of age or antiretroviral therapy. However, evidence for routine IPT without known exposure to TB in HIV-infected children is not convincing and is therefore not recommended. | en_ZA |
dc.description.uri | http://www.samj.org.za/index.php/samj/article/view/7189 | |
dc.description.version | Publisher's version | en_ZA |
dc.format.extent | 2 pages | en_ZA |
dc.identifier.citation | Schaaf, H. S., Cotton, M. F., Boon, G. P. G. & Jeena, P. M. 2013. Isoniazid preventive therapy in HIV-infected and -uninfected children (0 - 14 years). South African Medical Journal, 103(10):714-715, doi:10.7196/SAMJ.7189. | en_ZA |
dc.identifier.issn | 2078-5135 (online) | |
dc.identifier.issn | 0256-9574 (print) | |
dc.identifier.other | doi:10.7196/SAMJ.7189 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/94760 | |
dc.language.iso | en_ZA | en_ZA |
dc.publisher | Health & Medical Publishing Group | en_ZA |
dc.rights.holder | Authors retain copyright | en_ZA |
dc.subject | Isoniazid preventive therapy | en_ZA |
dc.subject | HIV-positive children | en_ZA |
dc.subject | Tuberculosis in children -- Prevention | en_ZA |
dc.title | Isoniazid preventive therapy in HIV-infected and -uninfected children (0 - 14 years) | en_ZA |
dc.type | Article | en_ZA |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- schaaf_isoniazid_2013.pdf
- Size:
- 546.89 KB
- Format:
- Adobe Portable Document Format
- Description:
- Download article